Literature DB >> 15385483

Role of B7 costimulatory molecules in mediating systemic and mucosal antibody responses to attenuated Salmonella enterica serovar Typhimurium and its cloned antigen.

Carlos A Garcia1, Michael Martin, Suzanne M Michalek.   

Abstract

The purpose of the present study was to evaluate the ability of an attenuated Salmonella enterica serovar Typhimurium vaccine strain to up-regulate B7-1 and B7-2 on antigen-presenting cells and to examine the functional roles these costimulatory molecules play in mediating immune responses to Salmonella and to an expressed cloned antigen, the saliva-binding region (SBR) of antigen I/II. In vitro stimulation of B cells (B220+), macrophages (CD11b+), and dendritic cells (CD11c+) with S. enterica serovar Typhimurium induced an up-regulation of B7-2 and, especially, B7-1 expression. The in vivo functional roles of B7-1, B7-2, and B7-1/2 were evaluated in BALB/c wild-type and B7-1, B7-2, and B7-1/2 knockout (KO) mice following intranasal immunization with the Salmonella expressing the cloned SBR. Differential requirements for B7-1 and B7-2 were observed upon primary and secondary immunizations. Compared to wild-type controls, B7-1 and B7-2 KO mice had reduced mucosal and systemic anti-Salmonella antibody responses after a single immunization, while only B7-1 KO mice exhibited suppressed anti-Salmonella antibody responses following the second immunization. Mucosal and systemic antibody responses to SBR were reduced following the primary immunization, whereas a compensatory role for either B7-1 or B7-2 was observed after the second immunization. B7-1/2 double KO mice failed to induce detectable levels of mucosal or systemic immunoglobulin A (IgA) or IgG antibody responses to either Salmonella or SBR. These findings demonstrate that B7-1 and B7-2 can play distinct as well as redundant roles for mediating mucosal and systemic antibody responses, which are likely dependent upon the nature of the antigen.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385483      PMCID: PMC517567          DOI: 10.1128/IAI.72.10.5824-5831.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

Review 1.  The B7-CD28 superfamily.

Authors:  Arlene H Sharpe; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

2.  CD28 costimulation accelerates IL-4 receptor sensitivity and IL-4-mediated Th2 differentiation.

Authors:  M Kubo; M Yamashita; R Abe; T Tada; K Okumura; J T Ransom; T Nakayama
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

3.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.

Authors:  V K Kuchroo; M P Das; J A Brown; A M Ranger; S S Zamvil; R A Sobel; H L Weiner; N Nabavi; L H Glimcher
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

4.  CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.

Authors:  L L Lanier; S O'Fallon; C Somoza; J H Phillips; P S Linsley; K Okumura; D Ito; M Azuma
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

5.  Critical role of CD28 in protective immunity against Salmonella typhimurium.

Authors:  H W Mittrücker; A Köhler; T W Mak; S H Kaufmann
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

6.  Antibody is required for protection against virulent but not attenuated Salmonella enterica serovar typhimurium.

Authors:  S J McSorley; M K Jenkins
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.

Authors:  K S Hathcock; G Laszlo; C Pucillo; P Linsley; R J Hodes
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

Review 8.  The B7 and CD28 receptor families.

Authors:  C H June; J A Bluestone; L M Nadler; C B Thompson
Journal:  Immunol Today       Date:  1994-07

9.  Role of B7 costimulatory molecules in the adjuvant activity of the heat-labile enterotoxin of Escherichia coli.

Authors:  Michael Martin; Arlene Sharpe; John D Clements; Suzanne M Michalek
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

10.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.

Authors:  D J Lenschow; S C Ho; H Sattar; L Rhee; G Gray; N Nabavi; K C Herold; J A Bluestone
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  1 in total

1.  Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.

Authors:  Ping Zhang; Janina P Lewis; Suzanne M Michalek; Jannet Katz
Journal:  Vaccine       Date:  2007-06-19       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.